[Substitution of pancreatic enzyme in premature infants and dystrophic children].
D000681:Amylases / Q000627:therapeutic use*; D001835:Body Weight; D002664:Child Nutritional Physiological Phenomena; D002675:Child, Preschool; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D008049:Lipase / Q000627:therapeutic use*; D009748:Nutrition Disorders / Q000188:drug therapy*; D010189:Pancreatic Juice / Q000201:enzymology; D014357:Trypsin / Q000627:therapeutic use*; D014801:Vitamin A / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use
D014801:Vitamin A; D005492:Folic Acid; D008049:Lipase; D000681:Amylases; D014357:Trypsin; D014805:Vitamin B 12
Pankreasferment-Substitution bei Frühgeborenen und dystrophischen Kindern.